StockData
GLAUKOS Corp logo

GLAUKOS Corp (GKOS) stock

GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30203% above fair value
$233.08−10.17 (-4.18%)

Close on Nov 18, 2026Market cap $13.80BP/E –Yield –

Glaukos shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Glaukos's shares outstanding was 61M at Sep 30, 2026. For fiscal 2025 it was 57M, up 8.4% from the year before. Over ten years it grew 12.6% a year on average. The highest annual figure on record is 57M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202557M+8.4%
FY2024Dec 31, 202453M+8.9%
FY2023Dec 31, 202348M+2.1%
FY2022Dec 31, 202247M+2.2%
FY2021Dec 31, 202146M+4.3%
FY2020Dec 31, 202044M+8.1%
FY2019Dec 31, 201941M+16.5%
FY2018Dec 31, 201835M+2.7%
FY2017Dec 31, 201734M-5.7%
FY2016Dec 31, 201636M+108.6%
FY2015Dec 31, 201517M+661.7%
FY2014Dec 31, 20142M+12.7%
FY2013Dec 31, 20132M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 202661M+6.6%
Q2 FY2026Jun 30, 202659M+2.8%
Q1 FY2026Mar 31, 202658M+2.4%
Q4 FY2025Dec 31, 202558M+3.4%
Q3 FY2025Sep 30, 202557M+4.3%
Q2 FY2025Jun 30, 202557M+12.8%
Q1 FY2025Mar 31, 202557M+14.2%
Q4 FY2024Dec 31, 202456M+13.8%
Q3 FY2024Sep 30, 202455M+13.1%
Q2 FY2024Jun 30, 202451M+5.0%
Q1 FY2024Mar 31, 202450M+3.5%
Q4 FY2023Dec 31, 202349M+2.4%
Q3 FY2023Sep 30, 202349M+2.2%
Q2 FY2023Jun 30, 202348M+2.0%
Q1 FY2023Mar 31, 202348M-3.3%
Q4 FY2022Dec 31, 202248M+1.7%
Q3 FY2022Sep 30, 202248M-3.5%
Q2 FY2022Jun 30, 202247M+2.3%
Q1 FY2022Mar 31, 202250M+8.3%
Q4 FY2021Dec 31, 202147M+4.1%
Q3 FY2021Sep 30, 202149M+10.3%
Q2 FY2021Jun 30, 202146M+4.4%
Q1 FY2021Mar 31, 202146M+4.4%
Q4 FY2020Dec 31, 202045M-18.1%
Q3 FY2020Sep 30, 202045M+21.4%
Q2 FY2020Jun 30, 202044M+21.6%
Q1 FY2020Mar 31, 202044M+20.9%
Q4 FY2019Dec 31, 201955M+52.8%
Q3 FY2019Sep 30, 201937M+3.6%
Q2 FY2019Jun 30, 201936M+4.4%
Q1 FY2019Mar 31, 201936M+4.4%
Q4 FY2018Dec 31, 201836M+4.2%
Q3 FY2018Sep 30, 201836M-5.6%
Q2 FY2018Jun 30, 201835M+1.8%
Q1 FY2018Mar 31, 201835M-8.1%
Q4 FY2017Dec 31, 201735M-6.7%
Q3 FY2017Sep 30, 201738M–
Q2 FY2017Jun 30, 201734M–
Q1 FY2017Mar 31, 201738M–
Q4 FY2016Dec 31, 201637M–

More Glaukos figures

See a number that looks wrong?